Nakamura, Toshitaka http://orcid.org/0000-0002-4248-2058
Mishima, Eikan http://orcid.org/0000-0002-3706-2745
Yamada, Naoya
Mourão, André Santos Dias
Trümbach, Dietrich http://orcid.org/0000-0001-9027-3704
Doll, Sebastian
Wanninger, Jonas
Lytton, Elena
Sennhenn, Peter
Nishida Xavier da Silva, Thamara http://orcid.org/0000-0001-5236-8470
Angeli, José Pedro Friedmann http://orcid.org/0000-0001-7706-1379
Sattler, Michael http://orcid.org/0000-0002-1594-0527
Proneth, Bettina http://orcid.org/0000-0002-4119-9437
Conrad, Marcus http://orcid.org/0000-0003-1140-5612
Article History
Received: 3 March 2023
Accepted: 25 September 2023
First Online: 13 November 2023
Competing interests
: M.C., B.P. and P.S. are co-founders and shareholders of ROSCUE Therapeutics. The other authors declare no competing interests.